SEC Form 4 · accession 0000899243-16-026610
REGENXBIO Inc. · RGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Abdun-Nabi
Director
Period of report
Aug 5, 2016
Accepted (ET)
Aug 9, 2016 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.69 | Aug 5, 2016 | A | 25,000 | A | — | Aug 5, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The option will vest in equal monthly installments over the 36 months following August 8, 2016, with immediate full vesting in the event of a change in control.